Siplizumab (Synonyms: MEDI-507) |
| カタログ番号GC69894 |
Siplizumab（MEDI-507）は、CD2に対する人工合成のIgG1モノクローナル抗体です。SiplizumabはT細胞を消耗し、T細胞の活性化を低下させ、T細胞の増殖を抑制し、naÏveおよびbona fide調節性T細胞を豊富に集積させることができます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 288392-69-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Siplizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Siplizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *